Clinical Research Directory
Browse clinical research sites, groups, and studies.
Isotretinoin Versus Excimer Light an Adjuvant in Treating Onychomycosis
Sponsor: Zagazig University
Summary
3 groups of patients with onychomycosis will be recruited. Group A will receive itraconazole alone. Group B will receive itraconazole + low dose isotretinoin and group C will be treated with itraconazole + excimer light sessions.
Official title: Efficacy of Low Dose Isotretinoin Versus Excimer Light as an Adjuvant for Itraconazole in Treatment of Onychomycosis: a Randomized Controlled Trial.
Key Details
Gender
All
Age Range
18 Years - 60 Years
Study Type
INTERVENTIONAL
Enrollment
36
Start Date
2024-07
Completion Date
2024-12
Last Updated
2024-07-03
Healthy Volunteers
No
Conditions
Interventions
ISOtretinoin 10 MG
Low dose isotretinoin as an adjuvant for itraconazole in treating onychomycosis
excimer light
excimer light as an adjuvant for itraconazole in treating onychomycosis
Itraconazole 200 mg
Itraconazole alone